Immuneering Corporation Expands Alliance with Bristol-Myers Squibb CAMBRIDGE, Mass., Jan. 29, 2014 /PRNewswire/ — Immuneering Corporation announced today that it has entered into an agreement to expand its existing relationship…
Read More
Immuneering Corporation Expands Alliance with Bristol-Myers Squibb CAMBRIDGE, Mass., Jan. 29, 2014 /PRNewswire/ — Immuneering Corporation announced today that it has entered into an agreement to expand its existing relationship…
Jan. 13, 2014– Teva Pharmaceuticals Industries Ltd. and Immuneering Corporation have co-authored a publication in PLOS ONE demonstrating that key genes respond differently to COPAXONE® (glatiramer acetate injection) versus a…
For decades, policies regarding generic medicines have sought to provide patients with economical access to safe and effective drugs, while encouraging the development of new therapies. This balance is becoming…